Search
Acrivon Therapeutics Inc
ACRVAdd to Watchlist
2.050USD
-0.010-0.48%
Market hours 09/24, 11:29（ET）
87.74MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.48%
5 Days
+20.59%
1 Month
-7.24%
6 Months
+28.13%
Year to Date
-14.94%
1 Year
+29.75%
Key Figures
2.118Open
2.170High
6.04KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
2.060Prev. Close
2.025Low
12.59KTurnover
LossP/E Static
0.92P/B
0.00%Div Yield TTM
-54.38%ROA
3.56052wk High
0.04Volume Ratio
-80.56MNet Profit
42.80MShares
-2.0016EPS TTM
1.95Beta
-60.39%ROE
1.27052wk Low
7.04%Amplitude
--Gross Margin
87.74MMarket Cap
2.29Reward/Risk
5.69%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Acrivon Therapeutics Inc Technical Analysis
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.43/-0.50
Revenue / Forecast
--/0.00
Acrivon Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolACRV
Number of employees75
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| RA Capital Management, LP | 28.57% |
| Chione, Ltd. | 8.99% |
| Sands Capital Ventures LLC | 4.96% |
| Blume-Jensen (Peter) | 4.86% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 28.62% |
| Hedge Fund | 13.42% |
| Corporation | 8.99% |
| Individual Investor | 5.98% |
Related Instruments
+3.25%
+0.43%
-0.52%
+0.49%
+0.40%
+0.28%
-0.35%
-0.21%
+0.37%
+1.29%
+1.14%
-0.29%
+0.07%
-0.22%
-1.55%
-1.13%
+1.59%
+0.34%
-1.44%
+0.76%Popular Instruments
51125.400
-364.600 (-0.71%)
30233.000
-244.900 (-0.80%)
7664.300
-42.700 (-0.55%)
14244.000
-178.000 (-1.23%)
65348.000
-781.000 (-1.18%)
6270.200
-19.800 (-0.32%)
96.023
+3.533 (+3.82%)
336.020
-1.000 (-0.30%)
221.920
-3.590 (-1.59%)
4248.200
-38.040 (-0.89%)
FAQs
What is the current price of Acrivon Therapeutics Inc (ACRV)?
The current price of Acrivon Therapeutics Inc (ACRV) is 2.06.
What is the symbol of Acrivon Therapeutics Inc?
The ticker symbol of Acrivon Therapeutics Inc is ACRV.
What is the 52-week high of Acrivon Therapeutics Inc?
The 52-week high of Acrivon Therapeutics Inc is 3.56.
What is the 52-week low of Acrivon Therapeutics Inc?
The 52-week low of Acrivon Therapeutics Inc is 1.27.
What is the market capitalization of Acrivon Therapeutics Inc?
The market capitalization of Acrivon Therapeutics Inc is 88.17M.
Is Acrivon Therapeutics Inc (ACRV) currently rated as Buy, Hold, or Sell?
According to analysts, Acrivon Therapeutics Inc (ACRV) has an overall rating of Buy, with a price target of 12.20.
What is the Earnings Per Share (EPS TTM) of Acrivon Therapeutics Inc (ACRV)?
The Earnings Per Share (EPS TTM) of Acrivon Therapeutics Inc (ACRV) is -2.00.